Zusammenfassung
Die Wirkung eines heterologen Antilymphocytenserums (ALS) vom Kaninchen auf die experimentelle allergische Encephalomyelitis (EAE) wurde in Versuchen an Sprague-Dawley-Ratten geprüft.
Durch eine ALS-Verabreichung, die vor, gleichzeitig mit, oder auch erst nach der Sensibilisierung eingeleitet wurde, konnte die EAE bei allen Versuchstieren vollkommen unterdrückt werden. Bereits aufgetretene Lähmungserscheinungen bildeten sich in 90% der Fälle unter ALS-Behandlung zurück.
Die im Vergleich zu anderen gebräuchlichen immunsuppressiven Maßnahmen besonders gute Wirkung von ALS auf die bereits ausgebrochene experimentelle Autoimmunerkrankung sowie mögliche Angriffspunkte von ALS in der pathogenetischen Entwicklung der EAE werden abschließend diskutiert.
Summary
The effect of a heterologous rabbit anti-lymphocyte serum (ALS) on the experimental allergic encephalomyelitis (EAE) was tested in Sprague Dawley rats:
EAE could be completely suppressed if ALS was given either before, simultaneously with, or after sensitization in all animals. The paralysis already developed could be abolished by ALS in 90%.
In comparison to other common immunosuppressive agents, the strong effect of ALS after the manifestation of the autoimmune disease as well as the possible sites of action of ALS during the pathogenesis of EAE are finally discussed.
Literatur
Abaza, H. N., B. Nolan, I. G. Watt, andM. F. Woodruff: The effect of antilymphocytic serum on the survival of renal homotransplants in dogs. Transplantation4, 618 (1966).
Appel, S. H., andM. B. Bornstein: The application of tissue culture to the study of experimental allergic encephalomyelitis. II. Serum factors responsible for demyelination. J. exp. Med.119, 303 (1964).
Balner, H., andH. Dersjant: Effects of antilymphocyte sera in primates. In: Antilymphocytic serum. CIBA-Foundation Study Group Nr 29, p. 85. London: Churchill 1967.
Barlow, C. F.: A study of abnormal blood-brain permeability in experimental allergic encephalomyelitis. J. Neuropath. exp. Neurol.15, 196 (1956).
Bekkum, D. W. van, G.D. Ledney, H. Balner, L. M. van Putten, andM. J. de Vries: Suppression of secondary disease following foreign bone marrow grafting with antilymphocyte-serum. In: Antilymphocytic serum. CIBA-Foundation Study Group No 29, p. 97. London: Churchill Ltd. 1967.
Berg, O., andB. Kallen: Studies of experimental allergic encephalomyelitis and multiple sclerosis with the aid of glia cell culture. Acta neurol. scand.41, Suppl. 13, 625 (1965).
Blaw, M. E., M. D. Cooper, andR. H. Good: Experimental allergic encephalomyelitis in agammaglobulinemic chickens. Science158, 1198 (1967).
Bollman, J. L., J. C. Cain, andJ. H. Grindlay: Techniques for collection of lymph from the liver, small intestine or thoracic duct of the rat. J. Lab. clin. Med.33, 1349 (1948).
Boak, J. L., M. Fox, andR. E. Wilson: Activity of lymphoid tissues from anti-lymphocyte-serum treated mice. Lancet1967 I, 750.
Bornstein, M. B., andJ. H. Appel: The application of tissue culture to the study of EAE: I. Patterns of demyelination. J. Neuropath. exp. Neurol.20, 141 (1961).
Brandriss, M. W., J. W. Smith, andR. M. Friedman: Suppression of experimental allergic encephalomyelitis by antimetabolites. Ann. N.Y. Acad. Sci.122, 356 (1965).
Brendel, W., andW. Land: Überraschende Ergebnisse durch intravenöse Therapie mit Antilymphocytenserum bei Organtransplantationen. Dtsch. med. Wschr.48, 2309 (1968).
Calne, D. B., andS. Leibowitz: Suppression of EAE by cytotoxic drugs. Nature (Lond.)197, 1309 (1963).
Condie, R. M., andT. Nicholas: Effect of total irradiation (TBR) on the development of experimental allergic encephalomyelitis (EAE). Fed. Proc.21, 43 (1962).
——, andR. A. Good: Prevention of experimental allergic encephalomyelitis by removal of the regional lymph node. Anat. Rec.127, 405 (1957).
Currey, H. L. F., andM. Ziff: Suppression of adjuvant disease in the rat by heterologous antilymphocyte globulin. J. exp. Med.127, 185 (1968).
Cutler, R. W. P., A. V. Lorenzo, andCh. F. Barlow: Brain vascular permeability to I125 gamma globulin and leukocytes in allergic encephalomyelitis. J. Neuropath. exp. Neurol.26, 558 (1967).
Denman, A. M., andE. P. Frenkel: Mode of action of antilymphocyte globulin. I. The distribution of rabbit antilymphocyte globulin injected into rats and mice. Immunology14, 107 (1968).
——, andE. J. Holborow: Immunosuppressive effects of lymphoid cell proliferation in mice receiving antilymphocyte globulin. Nature (Lond.)217, 117 (1968).
Field, E. J., andH. Miller: Studies in the inhibition of experimental allergic encephalomyelitis. Arch. int. Pharmacodyn.134, 76 (1961).
Frick, E.: Neuroallergie und multiple Sklerose. Med. Klin.62, 661 (1967).
——, u.H. Stickl: Lymphocytentransformation bei multipler Sklerose: Untersuchungen mit Liquor cerebrospinalis, Immunglobulinen und encephalitogem Protein. Klin. Wschr.19, 1066 (1968).
--, u.W. Land: Unveröffentlichte Ergebnisse.
Girard, P. F., G. Aimard etH. Pellet: Les immunodépresseurs I) Thérapeutique immuno-dépressive en neurologie. Presse méd.75, 967 (1967).
Gledhill, A. W.: Protective effect of antilymphocytic serum on murine lymphocytic choriomeningitis. Nature (Lond.)214, 178 (1967).
Guttmann, R. D., C. B. Carpenter, R. R. Lindquist, andJ. P. Merrill: An immunosuppressive site of action of heterologous antilymphocyte serum. Lancet1967 I, 248.
Hoyer, L. W., R. A. Good, andR. M. Condie: Experimental allergic encephalomyelitis: the effect of 6-mercaptopurine. J. exp. Med.116, 311 (1962).
James, K., andN. F. Anderson: Effect of anti-rat lymphocyte antibidy in humoral antibody formation. Nature (Lond.)213, 1195 (1967).
Kabat, E. A., andM. U. Mayer: Experimental immunochemistry, 2nd ed., p. 97. Springfield, Ill.: Ch. Thomas 1961.
Koprowski, H., andM. U. Fernandes: Autosensitization reaction in vitro. Contactual agglutination of sensitized lymph node cells in brain tissue culture accompanied by destruction of glial elements. J. exp. Med.116, 467 (1962).
Kosunen, T. U., B. H. Waksman, andI. K. Samuelson: Radioautographic study of cellular mechanism in delayed hypersensitivity. II. Experimental allergic encephalomyelitis. J. Neuropath. exp. Neurol.22, 367 (1963).
Lamoureux, G.: Persönliche Mitteilung.
Lampert, P.: Electron microscopic studies on ordinary and hyperacute experimental allergic encephalomyelitis. Acta neuropath. (Berl.)9, 99 (1967).
——, andS. Carpenter: Electron microscopic studies on the vascular permeability and the mechanism of demyelination in experimental allergic encephalomyelitis. J. Neuropath. exp. Neurol.24, 11 (1965).
Lance, E., andP. Medawar: ALS and Tolerance of homografts. 2nd Int. Congr. Transpl. Soc., New York 1968.
Land, W., R. Rudolph u.W. Brendel: In-vitro-Wirkung eines heterologen Antiserums auf Lymphocyten der Ratte: Eine elektronenmikroskopische Studie. Blut18, 1 (1968).
Leibowitz, W., M. H. Lessof, andL. A. Kennedy: The effect of anti-lymphocyte serum on experimental allergic encephalomyelitis in the guinea-pig. Clin. exp. Immunol.3, 753 (1968).
Levey, R. H., andP. B. Medawar: Some experiments on the action of antilymphoid antisera. Ann. N.Y. Acad. Sci.129, 164 (1966).
—— —— Nature and mode of action of antilymphocytic serum. Proc. nat. Acad. Sci. (Wash.)56, 1130 (1966).
Levine, S., A. Hirano, andH. M. Zimmerman: Hyperacute allergic encephalomyelitis. Electron microscopic observations. Amer. J. Path.47, 209 (1965).
Mehraein, P., R. Roscher, E. Frick, andW. Land: Vergleichende histologische Untersuchungen der experimentellen allergischen Encephalomyelitis bei Ratten nach der Behandlung mit Antilymphocytenserum. (In Vorbereitung.)
Mitchison, N. A.: Immunological tolerance and inhibition by hapten. Symposium on: The immune response and its suppression. Davos 1968.
Monaco, A. P., andD. Franco: Effect of antilymphocyte serum on H-2 antibody formation, induction of allograft immunity, and facilitation of tolerance to H-2 skin grafts. 2nd Int. Congr. of Transplant. Soc. New York 1968.
——, andP. S. Russel: Effect of antilymphocytic serum in mice, dogs and man. In: Antilymphocytic serum. CIBA-Foundation Study Group Nr. 29, p. 111. London: Churchill 1967.
Morris, P. J., andJ. F. Burke: Antilymphocyte serum and staphylococcal infection. Nature (Lond.)214, 1138 (1967).
Paterson, P. Y.: A study of experimental encephalomyelitis employing mammalian and non-mammalian nervous tissue. J. Immunol.78, 472 (1957).
—— Transfer of allergic encephalomyelitis in rats by means of lymph node cells. J. exp. Med.111, 119 (1960).
——, andN. E. Beisaw: Effect of whole body X-irradiation on induction of allergic encephalomyelitis in rats. J. Immunol.90, 532 (1963).
——, andE. W. Gerner: Cyclophosphamide inhibition of experimental allergic encephalomyelitis in Wistar rats. Proc. Soc. exp. Biol. (N.Y.)124, 928 (1967).
Pette, E., K. Mannweiler, O. Palacios, andB. Muetze: Phenomena of the cell membrane and their possible significance for the pathogenesis of the so-called auto-immune diseases of the nervous system. Ann. N.Y. Acad. Sci.122, 417 (1965).
Pichlmayr, R.: Wirkung eines heterologen Antilymphocytenserums auf die Transplantatabstoßung beim Hund. Klin. Wschr.44, 594 (1966).
—— Herstellung und Wirkung heterologer Antihundelymphocytenseren. Z. ges. exp. Med.143, 161 (1967).
—— u.W. Brendel: Homologe Lebertransplantation beim Hund unter immunsuppressiver Behandlung mit Antilymphocytenserum. Z. ges. exp. Med.146, 261 (1968).
Rauch, H. C., andS. Raffel: Cellular activities in hypersensitive reactions. IV. Specifically reactive cells in delayed hypersensitivity: Allergic encephalomyelitis. J. Immunol.93, 960 (1964).
Roscher, R.: Beeinflussung der experimentellen Encephalomyelitis mit heterologem Antilymphocytenserum bei der Ratte. Diss. München (in Vorbereitung).
Seitelberger, F.: Autoimmunologische Aspekte der Entmarkungsencephalitiden. Nervenarzt12, 525 (1967).
——, u.K. Jellinger: Die pathologische Anatomie der allergischen Erkrankungen des Nervensystems. Wien. klin. Wschr.75, 475 (1963).
Sherwin, A. L., M. Richter, J. B. Cosgrove, andB. Rose: Myelin-binding antibodies in experimental allergic encephalomyelitis. Science134, 1370 (1961).
Starzl, T. E., T. L. Marchioro, K. A. Porter, Y. Iwasaki, andG. J. Cerilli: The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg. Gynec. Obstet.124, 301 (1967).
Taub, R. N., andE. M. Lance: Effects of heterologous antilymphocyte serum on the distribution of 51-Cr, labelled lymph node cells in mice. Immunology15, 633 (1968).
Traeger, J., M. Carraz, D. Fries, J. Perrin, E. Saubier, J. Brochier, J.-P. Bernhardt, J. P. Archimbaud, P. Bonnet, C. Veyssere, R. Prevot, Y. Traeger-Fouillet, P. A. Bryon etY. Manuel: Préparation, propriétés et activités d'un sérum de cheval antilymphocyte humain. Pathol.-Biol.16, 1 (1968).
Trepel, F., R. Pichlmayr, J. Kimura, W. Brendel u.H. Begemann: Therapieversuche mit Antilymphocytenserum bei Autoaggressionskrankheiten des Menschen. Klin. Wschr.16, 856 (1968).
Turk, J. L., andD. A. Willoughby: An analysis of the multiplicity of the effect of anti-lymphocyte serum — a comparison with other immunosuppressive agents. Symposium on “The immune response and its suppression”, Davos 1968.
Waksman, B. H.: Encephalomyelitis and the autoallergic diseases. Int. Arch. Allergy14, Suppl., 1 (1959).
——: Animal investigations in autosensitization: nervous system. Ann. N.Y. Acad. Sci.124, 299 (1965).
—— andR. D. Adams: A histologic study of the early lesion in experimental allergic encephalomyelitis in the guinea pig and rabbit. Amer. J. Path.41, 135 (1962).
——S. Arbouys, andB. G. Arnason: The use of specific “lymphocyte” antisera to inhibit hypersensitive reactions of the “delayed” type. J. exp. Med.114, 997 (1961).
Woodruff, M. F. A., andN. F. Anderson: The effect of lymphocyte depletion by thoracic duct fistula and administration of anti-lymphocytic serum on the survival of skin homografts in rats. Ann. N.Y. Acad. Sci.120, 119 (1964).
Author information
Authors and Affiliations
Additional information
Auszugsweise vorgetragen auf der 85. Tagung der Deutschen Gesellschaft für Chirurgie, München, April 1968.
Mit Unterstützung durch die Deutsche Forschungsgemeinschaft.
Rights and permissions
About this article
Cite this article
Land, W., Frick, E., Roscher, R. et al. Wirkung eines heterologen Antilymphocytenserums auf die experimentelle allergische Encephalomyelitis. Klin Wochenschr 47, 633–640 (1969). https://doi.org/10.1007/BF01884358
Issue Date:
DOI: https://doi.org/10.1007/BF01884358